GILD · News · 20260817N
Revenue Performance and Mix
GILEAD SCIENCES, INC. · 2026-08-17 · Importance 48 · Surprise 40 · No source text
Gilead reported second-quarter revenue of $7.80 billion, up 10.6% year over year. The reported revenue exceeded analysts’ estimates. The digest identifies strong Q2 growth in Gilead’s HIV franchise but provides no segment dollar breakdown or sequential comparison.
Key facts
- Gilead Sciences Q2 revenue increased 10.6% year-over-year. source
- Gilead Sciences reported quarterly revenue of $7.80 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +9.6% | Gilead Sciences Q2 revenue increased 10.6% year-over-year. |